Date published: 2025-12-19

00800 4573 8000

SCBT Portrait Logo
Seach Input

β-1,4-GalNAc-T4 Activadores

GalNAc-T4 Activators refers to a group of compounds that potentially influence the function or regulation of GalNAc-T4 indirectly, primarily through their effects on glycosylation processes and related cellular pathways. These activators target various aspects of protein modification, Golgi apparatus function, and proteostasis, reflecting the potential involvement of GalNAc-T4 in these processes. Compounds like Benzyl-α-GalNAc, which inhibits mucin-type O-glycosylation, and Tunicamycin, an N-linked glycosylation inhibitor, can indirectly influence the glycosylation landscape within cells, potentially impacting GalNAc-T4 activity. Swainsonine, Castanospermine, and Kifunensine, by inhibiting specific glycosylation-related enzymes, demonstrate the interconnected nature of glycosylation pathways and their potential indirect impact on GalNAc-T4. Brefeldin A and Monensin disrupt Golgi apparatus function, a key site for glycosylation, potentially affecting the function and localization of GalNAc-T4 in glycosylation processes.

Deoxynojirimycin and 1-Deoxymannojirimycin, as α-glucosidase and α-mannosidase inhibitors, respectively, could indirectly influence GalNAc-T4 by affecting glycoprotein processing. Proteasome inhibitors like Clasto-Lactacystin β-Lactone and MG132 highlight the role of protein turnover in regulating enzymes like GalNAc-T4, potentially impacting its activity through modulation of protein stability. Ammonium Chloride, by affecting lysosomal pH, could impact lysosomal degradation pathways, indirectly influencing the activity and stability of GalNAc-T4. Overall, the study of GalNAc-T4 activators, primarily through indirect mechanisms, underscores the complexity of glycosylation processes and the importance of understanding how various factors, such as glycosylation inhibitors, Golgi function modulators, and proteostasis regulators, can influence the function of key enzymes involved in these processes. This approach is crucial for exploring the roles of enzymes like GalNAc-T4 in the broader context of cellular protein modification and stability.

VER TAMBIÉN ....

Nombre del productoNÚMERO DE CAS #Número de catálogoCantidadPrecioMENCIONESClasificación

Benzyl-2-acetamido-2-deoxy-α-D-galactopyranoside

3554-93-6sc-203427
sc-203427A
100 mg
1 g
$350.00
$3122.00
2
(0)

El bencilo-α-GalNAc es un inhibidor de la O-glicosilación de tipo mucina y puede afectar indirectamente a la actividad GalNAc-T4 al alterar la disponibilidad de sustrato.

Kifunensine

109944-15-2sc-201364
sc-201364A
sc-201364B
sc-201364C
1 mg
5 mg
10 mg
100 mg
$132.00
$529.00
$1005.00
$6125.00
25
(2)

La kifunensina, un inhibidor de la mannosidasa, puede afectar a la glicosilación ligada a N, lo que podría afectar a las vías relacionadas con GalNAc-T4.

Ceftriaxone, Disodium Salt, Hemiheptahydrate

104376-79-6sc-211050
sc-211050A
1 g
5 g
$175.00
$440.00
1
(1)

1-Deoximanojirimicina, otro inhibidor de α-manosidasa, podría influir indirectamente en GalNAc-T4 a través de efectos sobre el procesamiento de glicoproteínas.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$165.00
$575.00
60
(2)

Este inhibidor del proteasoma puede afectar al recambio proteico y podría influir indirectamente en la actividad de GalNAc-T4 modulando la estabilidad proteica.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

El MG132, otro inhibidor del proteasoma, podría afectar a las vías de degradación de proteínas, influyendo potencialmente en la función del GalNAc-T4.